{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T18:23:43Z","timestamp":1778610223994,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,31]],"date-time":"2015-07-31T00:00:00Z","timestamp":1438300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11596-015-1464-8","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T01:16:14Z","timestamp":1438218974000},"page":"525-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Qing\u2019e formula on circulating sclerostin levels in patients with postmenopausal osteoporosis"],"prefix":"10.1007","volume":"35","author":[{"given":"Yan-ping","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,31]]},"reference":[{"issue":"9","key":"1464_CR1","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00198-013-2353-2","volume":"24","author":"PK Fazeli","year":"2013","unstructured":"Fazeli PK, Ackerman KE, Pierce L, et al. Sclerostin and Pref-1 have differential effects on bone mineral density and strength parameters in adolescent athletes compared with non-athletes. Osteoporos Int, 2013,24(9):2433\u20132440","journal-title":"Osteoporos Int"},{"issue":"1","key":"1464_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1210\/jc.2013-3148","volume":"99","author":"B Dawson-Hughes","year":"2014","unstructured":"Dawson-Hughes B, Harris SS, Ceglia L, et al. Serum sclerostin levels vary with season. J Clin Endocrinol Metab, 2014,99(1):149\u2013152","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1464_CR3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jbmr.1823","volume":"28","author":"P Szulc","year":"2013","unstructured":"Szulc P, Bertholon C, Borel O, et al. Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study. J Bone Miner Res, 2013,28(4):855\u2013864","journal-title":"J Bone Miner Res"},{"issue":"2","key":"1464_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00198-012-1978-x","volume":"24","author":"P Garnero","year":"2013","unstructured":"Garnero P, Sornay-Rendu E, Munoz F, et al. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int, 2013,24(2):489\u2013494","journal-title":"Osteoporos Int"},{"issue":"12","key":"1464_CR5","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1002\/jbmr.479","volume":"26","author":"MS Ardawi","year":"2011","unstructured":"Ardawi MS, Al-Kadi HA, Rouzi AA, et al. Determinants of serum sclerostin in healthy pre- and postmenopausal women. J Bone Miner Res, 2011,26(12):2812\u20132822","journal-title":"J Bone Miner Res"},{"issue":"9","key":"1464_CR6","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1210\/jc.2013-2113","volume":"98","author":"C Durosier","year":"2013","unstructured":"Durosier C, Van Lierop A, Ferrari S, et al. Association of circulating sclerostin with bone mineral mass, microstructure, and turnover biochemical markers in healthy elderly Men and Women. J Clin Endocrinol Metab, 2013,98(9):3873\u20133883","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1464_CR7","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","volume":"97","author":"L Gennari","year":"2012","unstructured":"Gennari L, Merlotti D, Valenti R, et al. Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes. J Clin Endocrinol Metab, 2012,97(5):1737\u20131744","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1464_CR8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","volume":"26","author":"UI Modder","year":"2011","unstructured":"Modder UI, Hoey KA, Amin S, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res, 2011,26(2):373\u2013379","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1464_CR9","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-13-0862","volume":"170","author":"B Dawson-Hughes","year":"2014","unstructured":"Dawson-Hughes B, Harris S, Ceglia L, et al. Effect of supplemental vitamin D and calcium on serum sclerostin levels. Eur J Endocrinol, 2014,170(4):645\u2013650","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"1464_CR10","first-page":"850","volume":"21","author":"B Shuai","year":"2008","unstructured":"Shuai B, Shen L, Yang YP, et al. Effects of Chinese kidney-tonifying drugs on bone mineral density (BMD), biomechanics, 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 of ovariectomized osteoporosis rats. Zhongguo Gu Shang (Chinese), 2008,21(11):850\u2013853","journal-title":"Zhongguo Gu Shang (Chinese)"},{"issue":"3","key":"1464_CR11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4236\/cm.2014.53018","volume":"5","author":"B Shuai","year":"2014","unstructured":"Shuai B, Yang YP, Shen L, et al. Effect of Qing\u2019e formula on the expression of bone metabolic markers and VDR mRNA in postmenopausal osteoporosis patients. Chin Med (Chinese), 2014,5(3):145\u2013152","journal-title":"Chin Med (Chinese)"},{"issue":"11","key":"1464_CR12","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1210\/jc.2010-0720","volume":"95","author":"MT Drake","year":"2010","unstructured":"Drake MT, Srinivasan B, Modder UI, et al. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women. J Clin Endocrinol Metab, 2010,95(11):5056\u20135062","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1464_CR13","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4236\/cm.2014.52013","volume":"5","author":"B Shuai","year":"2014","unstructured":"Shuai B, Yang YP, Shen L, et al. Effect of Qing\u2019e pill plus salvia on non-traumatic osteonecrosis of the femoral head of idiopathic type in earlier stage: a case report of a twelve-month of period. Chin Med (Chinese), 2014,5(2):113\u2013117","journal-title":"Chin Med (Chinese)"},{"issue":"3","key":"1464_CR14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","volume":"68","author":"ME Brunkow","year":"2001","unstructured":"Brunkow ME, Gardner JC, Van Ness J, et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet, 2001,68(3):577\u2013589","journal-title":"Am J Hum Genet"},{"issue":"5","key":"1464_CR15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","volume":"10","author":"W Balemans","year":"2001","unstructured":"Balemans W, Ebeling M, Patel N, et al. Increase bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet, 2001,10(5):537\u2013543","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1464_CR16","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","volume":"110","author":"K Staehling-Hampton","year":"2002","unstructured":"Staehling-Hampton K, Proll S, Paeper BW, et al. A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. Am J Med Genet, 2002,110(2):144\u2013152","journal-title":"Am J Med Genet"},{"issue":"2","key":"1464_CR17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","volume":"39","author":"W Balemans","year":"2002","unstructured":"Balemans W, Patel N, Ebeling M, et al. Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet, 2002,39(2):91\u201397","journal-title":"J Med Genet"},{"issue":"6","key":"1464_CR18","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","volume":"23","author":"X Li","year":"2008","unstructured":"Li X, Ominsky MS, Niu QT, et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res, 2008,23(6):860\u2013869","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1464_CR19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","volume":"24","author":"X Li","year":"2009","unstructured":"Li X, Ominsky MS, Warmington KS, et al. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J Bone Miner Res, 2009,24(4):578\u2013588","journal-title":"J Bone Miner Res"},{"issue":"4","key":"1464_CR20","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","volume":"95","author":"FS Mirza","year":"2010","unstructured":"Mirza FS, Padhi ID, Raisz LG, et al. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab, 2010,95(4):1991\u20131997","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"1464_CR21","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.3760\/cma.j.issn.0366-6999.20130104","volume":"126","author":"XJ Xu","year":"2013","unstructured":"Xu XJ, Shen L, Yang YP, et al. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis. Chin Med J (Engl), 2013,126(13):2480\u20132484","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"1464_CR22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","volume":"26","author":"UI M\u00f6dder","year":"2011","unstructured":"M\u00f6dder UI, Hoey KA, Amin S, et al. Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. J Bone Miner Res, 2011,26(2):373\u2013379","journal-title":"J Bone Miner Res"},{"issue":"6","key":"1464_CR23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2265.2011.04315.x","volume":"76","author":"Z Sheng","year":"2012","unstructured":"Sheng Z, Tong D, Ou Y, et al. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in Central South Chinese postmenopausal women. Clin Endocrinol, 2012,76(6):797\u2013801","journal-title":"Clin Endocrinol"},{"issue":"10","key":"1464_CR24","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1056\/NEJM199709043371003","volume":"337","author":"B Dawson-Hughes","year":"1997","unstructured":"Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. New Engl J Med, 1997,337(10):670\u2013676","journal-title":"New Engl J Med"},{"issue":"11","key":"1464_CR25","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1210\/en.2005-0239","volume":"146","author":"T Bellido","year":"2005","unstructured":"Bellido T, Ali AA, Gubrij I, et al. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis. Endocrinology, 2005,146(11):4577\u20134583","journal-title":"Endocrinology"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1464-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-015-1464-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-015-1464-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T07:53:15Z","timestamp":1718005995000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-015-1464-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,31]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1464"],"URL":"https:\/\/doi.org\/10.1007\/s11596-015-1464-8","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,31]]}}}